Alnylam Pharmaceuticals, Inc. - Product Pipeline Review - 2016
Global Markets Direct’s, ‘Alnylam Pharmaceuticals, Inc. - Product Pipeline Review, 2016’, provides an overview of the Alnylam Pharmaceuticals, Inc.’s pharmaceutical research and development focus.
The report provides comprehensive information on the therapeutics under development by Alnylam Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.
Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.
- The report provides a snapshot of the pipeline therapeutic landscape of Alnylam Pharmaceuticals, Inc. - The report provides overview of Alnylam Pharmaceuticals, Inc. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Alnylam Pharmaceuticals, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Alnylam Pharmaceuticals, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
- Evaluate Alnylam Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Alnylam Pharmaceuticals, Inc. - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Alnylam Pharmaceuticals, Inc.’s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Our reports have been used by over 10K customers, including:
120 pages •
By Infiniti Research Limited
• Mar 2021
Global Voltage Regulator Market 2021-2025 The analyst has been monitoring the voltage regulator market and it is poised to grow by $ 10.21 bn during 2021-2025, progressing at a CAGR of almost 8% during the forecast period. Our report on voltage regulator market provides a holistic analysis, market size and forecast, trends,...
Market Overview: The global barrier materials market grew at a CAGR of around 6% during 2015-2020. Barrier materials refer to various packaging and enclosure solutions designed to minimize or prevent the permeability of gases, liquids or radiation. They are effective against oxygen, nitrogen,...
183 pages •
By Global Industry Analysts
• Apr 2021
- Global Personal Care Product Contract Manufacturing Market to Reach $27.4 Billion by 2027
- Amid the COVID-19 crisis, the global market for Personal Care Product Contract Manufacturing estimated at US$18.5 Billion in the year 2020, is projected to reach a revised size of US$27.4 Billion by 2027, growing...
2021 Global Microbiology Market--Supplier Shares by Country, SWOT Analysis, Latest Instrumentation and Strategic Profiles of Leading Competitors This 86-page report reviews major analyzers used for microbiology testing, including their operating characteristics, features and selling prices.The report is available...
438 pages •
By Global Industry Analysts
• Apr 2021
- Cuts Backs On Capital Spending in the Wake of COVID-19 Thwarts All Hopes of Growth for Titrators. Market Slumps by -6%
- The global market for Titrators (Automatic and Manual) is expected to slump by -6% in the year 2020 and thereafter recover and grow to reach US$470.5 million by the year 2027, trailing...
2021 Leading Plastics Companies SWOT Analysis--Capabilities, Goals and Strategies
This report is part of the Competitive Analysis Series prepared to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation to the leading competitors.
“LOU-064 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Sjogren’s Syndrome in 7 Major Markets. A detailed picture of the VIB4920 in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period...
“ANAMORELIN HCL - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Cancer Cachexia in 7 Major Markets. A detailed picture of the ANAMORELIN HCL in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for...
“KVD900 - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product forHereditary Angioedema in 7 Major Markets. A detailed picture of the KVD900 in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan, for the study period...
“UBLITUXIMAB + UMBRALISIB - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Diffuse Large B-Cell Lymphoma in 7 Major Markets. A detailed picture of the UBLITUXIMAB + UMBRALISIB in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the...
Research And Development
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.